ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, has been granted a new…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
